锥形束CT在标准与复杂EVAR技术评估中的前瞻性非随机研究
该前瞻性非随机研究纳入154例患者共170例主动脉手术,评估锥形束CT(CBCT)在标准与复杂腔内动脉瘤修复(EVAR)技术评估中的效用。结果显示CBCT检测内漏率(53%)显著高于DSA(14%)和CTA(46%),并在28%患者中发现阳性发现,其中18%促使术中或延迟干预;仅用DSA会遗漏79%的阳性发现。
要点
- CBCT检测内漏率53%,显著高于DSA的14%和CTA的46%。
- CBCT在28%患者中发现阳性发现,18%促使干预,F-BEVAR中阳性发现率更高(35% vs 16%)。
- 仅用DSA会遗漏79%的阳性发现,包括49%需二次干预的患者。
核心结论
- CBCT可可靠检测阳性发现,近五分之一患者因此立即修订手术,F-BEVAR患者中比例最高。
- CBCT检测任何内漏的比例高于DSA或CTA,但多数内漏仅被观察。
- 仅用DSA无法检测需要修订的阳性发现。
研究设计与样本
- 前瞻性数据库录入2016至2017年连续接受标准或复杂EVAR的患者,回顾性分析。
- 共154例患者(126例男性;平均年龄74±8岁),170例主动脉手术,包括85例开窗分支EVAR(F-BEVAR)、42例腹主动脉及胸主动脉EVAR、32例髂分支装置EVAR和11例主动脉相关干预。
- 技术评估使用CBCT(含或不含对比增强)、数字减影血管造影(DSA)和CT血管造影(CTA);慢性肾脏病3B或4期患者使用不含对比增强的CBCT。
主要发现
- F-BEVAR的辐射暴露和碘对比剂用量显著高于其他主动脉手术(174±101 Gy∙cm2 vs 1135±113 Gy∙cm2,144±60 mL vs 122±49 mL,P < .05)。
- 主动脉手术的平均有效剂量(ED)为74±36 mSv,透视18±18 mSv,DSA采集7±7 mSv,CBCT 15±7 mSv,CTA成像34±17 mSv(P < .001)。
- CBCT检测内漏率53%,显著高于DSA的14%和CTA的46%(P < .001)。
- CBCT在43例患者(28%)中识别52项阳性发现,F-BEVAR高于其他主动脉手术(35% vs 16%;P = .01)。
- 阳性发现包括支架压缩或扭结29例(17%)、I型或III型内漏16例(10%)、动脉夹层或血栓7例(5%);28例(18%)阳性发现促使术中(17%)或延迟干预(1%),另15例(10%)轻微阳性发现仅观察无临床后果。
临床怎么用
- CBCT可用于标准与复杂EVAR的术中技术评估,尤其F-BEVAR患者阳性发现率更高。
- CBCT检测内漏敏感性高于DSA和CTA,但多数内漏仅需观察。
- 仅依赖DSA可能遗漏需干预的阳性发现,CBCT可辅助术中决策。
- 用CBCT替代DSA和CTA可减少碘对比剂用量和辐射有效剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to analyze the utility of cone beam computed tomography (CBCT) for technical assessment of standard and complex endovascular aneurysm repair (EVAR). METHODS: Data of consecutive patients who underwent standard or complex EVAR in 2016 and 2017 at our institution were entered into a prospective database and analyzed retrospectively. There were 154 patients (126 male; mean age, 74 ± 8 years) enrolled in a prospective study between 2016 and 2017. A total of 170 aortic procedures were investigated, including 85 fenestrated-branched EVARs (F-BEVARs), 42 abdominal and thoracic EVARs, 32 EVARs with iliac branch devices, and 11 aorta-related interventions. Technical assessment was done using CBCT with and without contrast enhancement, digital subtraction angiography (DSA), and computed tomography angiography (CTA). Patients with stage 3B or stage 4 chronic kidney disease had CBCT without contrast enhancement. Radiation exposure (mean dose-area product), effective dose (ED), and amount of iodine contrast agent were analyzed. End points were presence of any endoleak, positive findings warranting possible intervention (stent kink or compression, type I or type III endoleak, dissection, thrombus), and need for secondary intervention. RESULTS: Radiation exposure and amount of iodine contrast agent were significantly higher (P < .05) for F-BEVAR compared with other aortic procedures (174±101 Gy∙cm2 vs 1135±113 Gy∙cm2 and 144±60 mL vs 122±49 mL). ED averaged 74±36 mSv for the aortic procedure, 18 ± 18 mSv for fluoroscopy, 7 ± 7 mSv for DSA acquisition, 15±7 mSv for CBCT, and 34±17 mSv for CTA imaging (P < .001). Endoleak detection was significantly higher (P < .001) with CBCT (53%) compared with DSA (14%) and CTA (46%). CBCT identified 52 positive findings in 43 patients (28%), higher for F-BEVAR compared with other aortic procedures (35% vs 16%; P = .01). Positive findings included stent compression or kink in 29 patients (17%), type I or type III endoleak in 16 patients (10%), and arterial dissection or thrombus in 7 patients (5%). Of these, 28 patients (18%) had positive findings that prompted an intraoperative (17%) or delayed intervention (1%). Another 15 patients (10%) with minor positive findings were observed with no clinical consequence. DSA alone would not have detected positive findings in 34 of 43 patients (79%), including 21 patients (49%) who needed secondary interventions. CTA diagnosed two (1%) additional endoleaks requiring intervention (one type IC, one type IIIC) that were not diagnosed by CBCT. Replacing DSA and CTA by CBCT would have resulted in 53% ± 13% reduction in amount of iodine contrast agent and 55% ± 12% reduction in ED (P < .05). CONCLUSIONS: CBCT reliably detected positive findings prompting immediate revisions in nearly one of five patients, with the highest rates among F-BEVAR patients. Detection of any endoleak was higher with CBCT compared with DSA or CTA, but most endoleaks were observed. DSA alone failed to detect positive findings warranting revisions.
引用
- Tenorio ER, Oderich GS, Sandri GA, et al. Prospective nonrandomized study to evaluate cone beam computed tomography for technical assessment of standard and complex endovascular aortic repair. J Vasc Surg. 2019. PMID: 31611108. doi:10.1016/j.jvs.2019.07.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。